Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netupitant/Palonosetron vs Palonosetron in MEC
NCT01339260Phase 3Completed
- Sponsor
- Helsinn
- Start
- Apr 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of netupitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by Helsinn. Started Apr 2011; status: completed.
02
Drugs
netupitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01339260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01339260.